Read more
Careful choice of nanoparticles as targets and in drug delivery routes enhances therapeutic efficacy in cancer. This book discusses nanotechnological developments of interfering RNA-based nanoparticles and delivery vehicles, validated therapeutic RNAi-molecular target interactions, and explains the results of clinical and preclinical trials.
List of contents
Chapter 01
The advantages and versatility of carrier—free nanodrugs and nanoparticles systems for cancer therapy
Chapter 02
Strategies, design, and chemistry in siRNA delivery vehicles systems for cancer therapy
Chapter 03
DNA/RNA nanoparticles structures for siRNA deliver applications
Chapter 04
Co-delivery in nanoparticle-based siRNA for cancer therapy
Chapter 05
Small interfering RNAs (siRNAs), MicroRNAs and NPs in gynecological cancers
Chapter 06
Nanoparticle–based RNA (siRNA) combination therapy toward overcoming drug resistance in cancer
Chapter 07
Imaging modalities delivery of RNAi therapeutics in cancer therapy and clinical applications
Chapter 08
Recent development of Silica nanoparticles as delivery biomedical applications for cancer imaging and therapy
Chapter 09
Application of carbon nanotubes (CNTs) in cancer vaccines as drug delivery tools
Chapter 10
Development of oligonucleotides delivery, (siRNAs), and (miRNA) systems for anticancer therapeutic strategy immunotherapy
Chapter 11
Pharmacogenomics-synergistic strategies using a chimerical peptide for enhanced chemotherapy based on ROS and DNA nanosystem
Chapter 12
Pharmacokinetics, biodistribution and therapeutic applications of recently-developed siRNA and DNA repair genes recurrence
Chapter 13
Nanotechnologies assemblies of siRNA and chemotherapeutic drugs co-delivered for cancer therapeutic applications
Chapter 14
Targeted systemic combinatorial delivery of siRNA polyplexes-Functional quantum dot-siRNA nanoplexes
Chapter 15
Recent advances of nanotechnologies for cancer immunotherapy treatment
List of Abbreviations
About the author
Prof. Loutfy H. Madkour is a professor of physical chemistry and nanoscience at Tanta University (Egypt). He received his BSc, MSc, and PhD in physical chemistry from the Cairo, Minia, and Tanta universities in Egypt, respectively. He has published 200 peer-reviewed original research articles, 20 review articles, and 8 books. He is an editorial board member of several international journals, including International Journal of Industrial Chemistry (IJIC-Springer), International Journal of Ground Sediment & Water, Global Drugs and Therapeutics, Chronicles of Pharmaceutical Science, Journal of Targeted Drug Delivery, UPI Journal of Pharmaceutical, Medical and Health Sciences, Global Journal of Nanomedicine, Clinical Pharmacology and Toxicology Research, Journal of Pharmacology & Pharmaceutical Research, LOJ Pharmacology & Clinical Research, CPQ Medicine, Pharmaceutical Sciences & Analytical Research Journal, Japan Journal of Research, Organic & Medicinal Chemistry International Journal, Nanotechnology & Applications, Materials Science Journal, Journal of Chemical Science and Chemical Engineering (Journals of– JCSCE), United Journal of Nanotechnology and Medicine, Clinical Practice (Therapy) journal, Journal of Materials New Horizons, Journal of Radiology and Medical Imaging. MedDocs Publishers, World Journal of Pharmacy and Pharmaceutical Sciences WJPPS and Journal of Material Science and Technology Research – RBM.
Summary
Careful choice of nanoparticles as targets and in drug delivery routes enhances therapeutic efficacy in cancer. This book discusses nanotechnological developments of interfering RNA-based nanoparticles and delivery vehicles, validated therapeutic RNAi-molecular target interactions, and explains the results of clinical and preclinical trials.
